Trials / Completed
CompletedNCT07084961
A Pharmacodynamic Study of TS-172 in Healthy Adult Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 18 Years – 39 Years
- Healthy volunteers
- Accepted
Summary
An open-label, single-center, crossover study to evaluate the impact of administration timing of TS-172 on the pharmacodynamics in healthy adult male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-172 | Oral administration of TS-172 20 mg immediately before meal |
| DRUG | TS-172 | Oral administration of TS-172 20 mg immediately after meal |
Timeline
- Start date
- 2025-08-05
- Primary completion
- 2025-09-11
- Completion
- 2025-09-16
- First posted
- 2025-07-25
- Last updated
- 2025-10-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT07084961. Inclusion in this directory is not an endorsement.